03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Tasmar* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Omnipharma |
Distributor | Omnipharma |
Laboratory | Roche |
Responsible Party | F. Hoffmann La Roche Ltd |
Origin | Switzerland |
Manufacturer | F. Hoffmann La Roche Ltd |
Origin | Switzerland |
ATC | N04BX01 |
Tasmar* :
Tasmar* :
Tasmar* :
Tasmar* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Abnormal dreams | Very Common |
ALT increased | Common |
Binge eating | Not known |
Chest pain | Common |
Chromaturia | Common |
Compulsive shopping | Not known |
Confusional state | Very Common |
Constipation | Common |
Decreased appetite | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Very Common |
Dry mouth (Xerostomia) | Common |
Dyskinesia | Very Common |
Dyspepsia | Common |
Dystonia | Very Common |
Hallucination | Very Common |
Headache | Very Common |
Hepatocellular injury | Uncommon |
Hyperhidrosis | Common |
Hypersexuality | Not known |
Hypokinesia | Common |
Impulse-control disorder | Rare |
Influenza-like illness | Common |
Libido increased | Not known |
Nausea | Very Common |
Neuroleptic malignant syndrome | Rare |
Orthostatic intolerance | Very Common |
Pathological gambling | Not known |
Rhabdomyolysis | Not known |
Sleep disorder (Sleep disturbance) | Very Common |
Somnolence | Very Common |
Syncope | Common |
Upper respiratory tract infection | Common |
Vomiting | Common |
Tasmar* :
Different Units By MoH Code
Tasmar* MoH 1603 :
Form | Tablet, Film-Coated |
Package Size | Box of 30 |
Strength | 100mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 78795 |
Submission date | 01/01/1999 |
Registration Year | 1999 |
Archived Date | 2014 |
Price Comparison
● Country: | Switzerland | |
● Package Size: | 30 | |
● Public Price: | 71.15 CHF | ( 7,358,333.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,3717 CHF | ( 206,840.00 LBP ) |
● Exfactory Price: | 47.71 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Sweden | |
● Package Size: | 100 | |
● Public Price: | 2101.6 SEK | ( 17,670,252.80 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 21,016 SEK | ( 176,568.00 LBP ) |
● Pharmacy Price: | 2015.05 SEK | ( 16942540.4 LBP ) |
● Pricing Date: | 23/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 100 | |
● Public Price: | 165.33 EUR | ( 16,016,509.08 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 1,6533 EUR | ( 96,876.00 LBP ) |
● Pricing Date: | 17/07/2018 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 100 | |
● Public Price: | 125.45 EUR | ( 12,153,094.20 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 1,2545 EUR | ( 96,876.00 LBP ) |
● Exfactory Price: | 115 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Turkey | |
● Package Size: | 100 | |
● Public Price: | 480.32 TRY | ( 1,287,257.60 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 4,8032 TRY | ( 10,720.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Denmark |
● Package Size: | 100 |
● Reference: | Danish Medicine Agency |
● Pricing Date: | 20/02/2019 |
● Type: | Medicine Non Marketed |
● Country: | New Zealand |
● Package Size: | 100 tab |
● Exfactory Price: | 152.38 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/04/2020 |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File